标题
Recent advances and future of immunotherapy for glioblastoma
作者
关键词
-
出版物
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 16, Issue 10, Pages 1245-1264
出版商
Informa UK Limited
发表日期
2016-07-13
DOI
10.1080/14712598.2016.1212012
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Hemorrhage from cerebral cavernous malformations: a systematic pooled analysis
- (2017) Bradley A. Gross et al. JOURNAL OF NEUROSURGERY
- Immune suppressive mechanisms in the tumor microenvironment
- (2016) David H Munn et al. CURRENT OPINION IN IMMUNOLOGY
- ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma
- (2016) Carl Koschmann et al. Science Translational Medicine
- Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium
- (2016) Eileen S. Kim et al. Journal of Immunology Research
- Pathology, molecular mechanisms and markers of gliomas: new insight and new challenges
- (2015) Werner Paulus ACTA NEUROPATHOLOGICA
- Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
- (2015) David Castel et al. ACTA NEUROPATHOLOGICA
- Immunotherapy with dendritic cells loaded with glioblastoma stem cells: from preclinical to clinical studies
- (2015) Gaetano Finocchiaro et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Awakening the immune system with radiation: Optimal dose and fractionation
- (2015) Saumil J. Gandhi et al. CANCER LETTERS
- Bioactivity and Safety of IL13R 2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
- (2015) C. E. Brown et al. CLINICAL CANCER RESEARCH
- A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma
- (2015) Manfred Westphal et al. EUROPEAN JOURNAL OF CANCER
- A Genetically Modified Adenoviral Vector with a Phage Display-Derived Peptide Incorporated into Fiber Fibritin Chimera Prolongs Survival in Experimental Glioma
- (2015) Julius W. Kim et al. HUMAN GENE THERAPY
- Overview of current immunotherapeutic strategies for glioma
- (2015) Anda-Alexandra Calinescu et al. Immunotherapy
- The role of checkpoints in the treatment of GBM
- (2015) Jennifer E. Kim et al. JOURNAL OF NEURO-ONCOLOGY
- Prognostic significance of relative 1p/19q codeletion in oligodendroglial tumors
- (2015) Marc C. Chamberlain et al. JOURNAL OF NEURO-ONCOLOGY
- Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
- (2015) Duane A. Mitchell et al. NATURE
- Mutational landscape and clonal architecture in grade II and III gliomas
- (2015) Hiromichi Suzuki et al. NATURE GENETICS
- Prospects of immune checkpoint modulators in the treatment of glioblastoma
- (2015) Matthias Preusser et al. Nature Reviews Neurology
- Sui generis: gene therapy and delivery systems for the treatment of glioblastoma
- (2015) J. R. Kane et al. NEURO-ONCOLOGY
- Isocitrate dehydrogenase mutations in gliomas
- (2015) Matthew S. Waitkus et al. NEURO-ONCOLOGY
- Outcomes of the ACT III Study
- (2015) Benjamin M. Zussman et al. NEUROSURGERY
- Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
- (2015) Jeanette E. Eckel-Passow et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Next-generation sequencing: hype and hope for development of personalized radiation therapy?
- (2015) Ingeborg Tinhofer et al. Radiation Oncology
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
- (2015) B. M. Carreno et al. SCIENCE
- Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma
- (2015) Laura A. Johnson et al. Science Translational Medicine
- Recent Technical Advances and Indications for Radiation Therapy in Low-Grade Glioma
- (2015) Michael D. Chan SEMINARS IN RADIATION ONCOLOGY
- Detection of Human Cytomegalovirus in Different Histopathological Types of Glioma in Iraqi Patients
- (2015) Haidar A. Shamran et al. Biomed Research International
- Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation
- (2015) Yafei Hou et al. Journal for ImmunoTherapy of Cancer
- Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
- (2015) Yuchen Jiao et al. Oncotarget
- B Cells Are Critical to T-cell—Mediated Antitumor Immunity Induced by a Combined Immune-Stimulatory/Conditionally Cytotoxic Therapy for Glioblastoma
- (2015) Marianela Candolfi et al. NEOPLASIA
- Autologous T-cell Therapy for Cytomegalovirus as a Consolidative Treatment for Recurrent Glioblastoma
- (2014) A. Schuessler et al. CANCER RESEARCH
- Sox2 Is Required to Maintain Cancer Stem Cells in a Mouse Model of High-Grade Oligodendroglioma
- (2014) Rebecca Favaro et al. CANCER RESEARCH
- Blocking Immunosuppressive Checkpoints for Glioma Therapy: The More the Merrier!
- (2014) M. G. Castro et al. CLINICAL CANCER RESEARCH
- Immunotherapy for Brain Cancer: Recent Progress and Future Promise
- (2014) C. M. Jackson et al. CLINICAL CANCER RESEARCH
- Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors
- (2014) D. A. Wainwright et al. CLINICAL CANCER RESEARCH
- Tim-3 on Peripheral CD4+ and CD8+ T Cells Is Involved in the Development of Glioma
- (2014) Song Han et al. DNA AND CELL BIOLOGY
- Adenoviral vector-mediated gene therapy for gliomas: coming of age
- (2014) Maria G Castro et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Antigen-Specific Immune Responses and Clinical Outcome After Vaccination With Glioma-Associated Antigen Peptides and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Children With Newly Diagnosed Malignant Brainstem and Nonbrainstem Gliomas
- (2014) Ian F. Pollack et al. JOURNAL OF CLINICAL ONCOLOGY
- Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme
- (2014) Martin K. Hunn et al. JOURNAL OF NEURO-ONCOLOGY
- Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma
- (2014) Eiichi Ishikawa et al. JOURNAL OF NEUROSURGERY
- A vaccine targeting mutant IDH1 induces antitumour immunity
- (2014) Theresa Schumacher et al. NATURE
- Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma
- (2014) Marta Penas-Prado et al. NEURO-ONCOLOGY
- Immunotherapy advances for glioblastoma
- (2014) D. A. Reardon et al. NEURO-ONCOLOGY
- FIRST-IN-HUMAN PHASE I CLINICAL TRIAL OF ONCOLYTIC DELTA-24-RGD (DNX-2401) WITH BIOLOGICAL ENDPOINTS: IMPLICATIONS FOR VIRO- IMMUNOTHERAPY
- (2014) F. F. Lang et al. NEURO-ONCOLOGY
- Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
- (2014) Anna Sophie Berghoff et al. NEURO-ONCOLOGY
- Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
- (2014) Ray R. Zhang et al. NEUROSURGERY
- Human Cytomegalovirus Tegument Protein pp65 Is Detected in All Intra- and Extra-Axial Brain Tumours Independent of the Tumour Type or Grade
- (2014) Sylwia Libard et al. PLoS One
- Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205
- (2014) M. V. Dhodapkar et al. Science Translational Medicine
- Tim-3: An Emerging Target in the Cancer Immunotherapy Landscape
- (2014) A. C. Anderson Cancer Immunology Research
- Current Vaccine Trials in Glioblastoma: A Review
- (2014) Linda W. Xu et al. Journal of Immunology Research
- Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death
- (2014) Encouse B Golden et al. OncoImmunology
- Cytokine responsiveness of CD8+ T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients
- (2014) Richard G Everson et al. Journal for ImmunoTherapy of Cancer
- Chromatin Remodeling Defects in Pediatric and Young Adult Glioblastoma: A Tale of a Variant Histone 3 Tail
- (2013) Adam M. Fontebasso et al. BRAIN PATHOLOGY
- Targeting a Glioblastoma Cancer Stem-Cell Population Defined by EGF Receptor Variant III
- (2013) D. R. Emlet et al. CANCER RESEARCH
- Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma
- (2013) R. Shao et al. CARCINOGENESIS
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
- (2013) A. Jimeno et al. CLINICAL CANCER RESEARCH
- Gliomas Promote Immunosuppression through Induction of B7-H1 Expression in Tumor-Associated Macrophages
- (2013) O. Bloch et al. CLINICAL CANCER RESEARCH
- Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
- (2013) Thomas F Gajewski et al. CURRENT OPINION IN IMMUNOLOGY
- An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma
- (2013) David A Reardon et al. Expert Review of Vaccines
- Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors
- (2013) Vidyalakshmi Chandramohan et al. Future Oncology
- The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures
- (2013) Jérôme Galon et al. IMMUNITY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Anti-PD-1 Blockade and Stereotactic Radiation Produce Long-Term Survival in Mice With Intracranial Gliomas
- (2013) Jing Zeng et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
- (2013) Nienke van Rooij et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety, Efficacy, and Biomarkers of Nivolumab With Vaccine in Ipilimumab-Refractory or -Naive Melanoma
- (2013) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell–mediated glioma rejection
- (2013) Johannes vom Berg et al. JOURNAL OF EXPERIMENTAL MEDICINE
- High prevalence of HCMV and viral load in tumor tissues and peripheral blood of glioblastoma multiforme patients
- (2013) Claudia Januário dos Santos et al. JOURNAL OF MEDICAL VIROLOGY
- PD-L1 Expression by Neurons Nearby Tumors Indicates Better Prognosis in Glioblastoma Patients
- (2013) Y. Liu et al. JOURNAL OF NEUROSCIENCE
- Pediatric Phase II Trials of Poly-ICLC in the Management of Newly Diagnosed and Recurrent Brain Tumors
- (2013) Lisa L.R. Hartman et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Oncolytic Virotherapy and Immunogenic Cancer Cell Death: Sharpening the Sword for Improved Cancer Treatment Strategies
- (2013) Samuel T Workenhe et al. MOLECULAR THERAPY
- Recurrent H3.3 alterations in childhood tumors
- (2013) Anders M Lindroth et al. NATURE GENETICS
- Heat-shock protein peptide complex–96 vaccination for recurrent glioblastoma: a phase II, single-arm trial
- (2013) Orin Bloch et al. NEURO-ONCOLOGY
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- The nature of activatory and tolerogenic dendritic cell-derived signal II
- (2013) Ghaith Bakdash et al. Frontiers in Immunology
- Prognostic Relevance of c-MycandBMI1Expression in Patients With Glioblastoma
- (2012) Tonia Cenci et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Human Leukocyte Antigen-G Is Frequently Expressed in Glioblastoma and May Be Induced in Vitro by Combined 5-Aza-2′-Deoxycytidine and Interferon-γ Treatments
- (2012) Isabela J. Wastowski et al. AMERICAN JOURNAL OF PATHOLOGY
- α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial
- (2012) Yasuto Akiyama et al. BMC CANCER
- Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
- (2012) Dominik Sturm et al. CANCER CELL
- Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
- (2012) Surasak Phuphanich et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors
- (2012) Sofia Eberstål et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Suicide gene therapy in cancer: Where do we stand now?
- (2012) Sónia Duarte et al. CANCER LETTERS
- Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expression
- (2012) Sreelatha Gopinath et al. CARCINOGENESIS
- IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival
- (2012) D. A. Wainwright et al. CLINICAL CANCER RESEARCH
- The Definition of Primary and Secondary Glioblastoma
- (2012) H. Ohgaki et al. CLINICAL CANCER RESEARCH
- The cancer antigenome
- (2012) Bianca Heemskerk et al. EMBO JOURNAL
- Expression of β-catenin and E- and N-cadherin in human brainstem gliomas and clinicopathological correlations
- (2012) Wenhao Wu et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Sequential Immunotherapy by Vaccination With GM-CSF–expressing Glioma Cells and CTLA-4 Blockade Effectively Treats Established Murine Intracranial Tumors
- (2012) Pankaj Agarwalla et al. JOURNAL OF IMMUNOTHERAPY
- The art of gene therapy for glioma: a review of the challenging road to the bedside
- (2012) Alex Tobias et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
- (2012) Kim Margolin et al. LANCET ONCOLOGY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunotherapy against the radial glia marker GLAST effectively triggers specific antitumor effectors without autoimmunity
- (2012) Gabriele Cantini et al. OncoImmunology
- Monoclonal antibody blockade of IL-2 receptor during lymphopenia selectively depletes regulatory T cells in mice and humans
- (2011) D. A. Mitchell et al. BLOOD
- β-catenin and Gli1 are prognostic markers in glioblastoma
- (2011) Marco Rossi et al. CANCER BIOLOGY & THERAPY
- MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing
- (2011) Lei Bao et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
- (2011) S.-R. Woo et al. CANCER RESEARCH
- Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment
- (2011) Christopher Jackson et al. Clinical & Developmental Immunology
- Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide
- (2011) Stuart A. Grossman et al. CLINICAL CANCER RESEARCH
- Characterization of Molecular Genetic Alterations in GBMs Highlights a Distinctive Molecular Profile in Young Adults
- (2011) Prerana Jha et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1
- (2011) Lin Cheng et al. EMBO JOURNAL
- Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
- (2011) N. Joller et al. JOURNAL OF IMMUNOLOGY
- Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells
- (2011) Nina Baron et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Combined Flt3L/TK Gene Therapy Induces Immunological Surveillance Which Mediates an Immune Response Against a Surrogate Brain Tumor Neoantigen
- (2011) Gwendalyn D King et al. MOLECULAR THERAPY
- Engineering Dendritic Cells to Enhance Cancer Immunotherapy
- (2011) Jeanette E Boudreau et al. MOLECULAR THERAPY
- Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study
- (2011) A. Carpentier et al. NEURO-ONCOLOGY
- Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma
- (2010) E. G. Van Meir et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis and radiosensitization and overcomes temozolomide resistance in malignant gliomas
- (2010) I M Germano et al. CANCER GENE THERAPY
- Polycomb genes expression as a predictor of poor clinical outcome in children with medulloblastoma
- (2010) Magdalena Zakrzewska et al. CHILDS NERVOUS SYSTEM
- Wnt/beta-Catenin pathway in human glioma: expression pattern and clinical/prognostic correlations
- (2010) Ce Liu et al. CLINICAL AND EXPERIMENTAL MEDICINE
- HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors
- (2010) N. Ahmed et al. CLINICAL CANCER RESEARCH
- Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy
- (2010) Robert M. Prins et al. CLINICAL CANCER RESEARCH
- Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
- (2010) John H. Sampson et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Trial of a Personalized Peptide Vaccine for Patients Positive for Human Leukocyte Antigen–A24 With Recurrent or Progressive Glioblastoma Multiforme
- (2010) Mizuhiko Terasaki et al. JOURNAL OF CLINICAL ONCOLOGY
- Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
- (2010) Hideho Okada et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of CD74 in high grade gliomas: a potential role in temozolomide resistance
- (2010) Gaspar J. Kitange et al. JOURNAL OF NEURO-ONCOLOGY
- The detection of CMV pp65 and IE1 in glioblastoma multiforme
- (2010) Kenneth G. Lucas et al. JOURNAL OF NEURO-ONCOLOGY
- Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions
- (2010) Tony Avril et al. JOURNAL OF NEUROIMMUNOLOGY
- Expression of PROX1 Is a Common Feature of High-Grade Malignant Astrocytic Gliomas
- (2010) Tamador Elsir et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes
- (2010) R. Senetta et al. NEURO-ONCOLOGY
- A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma
- (2010) M. R. Rosenfeld et al. NEURO-ONCOLOGY
- Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
- (2010) J. H. Sampson et al. NEURO-ONCOLOGY
- Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: An unexpected prognostic significance?
- (2010) Leos Kren et al. NEUROPATHOLOGY
- Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells
- (2010) F. Orzan et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Misregulated E-Cadherin Expression Associated with an Aggressive Brain Tumor Phenotype
- (2010) Laura J. Lewis-Tuffin et al. PLoS One
- SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma
- (2009) Myung Jin Son et al. Cell Stem Cell
- TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines
- (2009) William D. Hastings et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients
- (2009) Amy B Heimberger et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Caveolin-1 expression in diffuse gliomas: correlation with the proliferation index, epidermal growth factor receptor, p53, and 1p/19q status
- (2009) Valeria Barresi et al. HUMAN PATHOLOGY
- Costimulatory and coinhibitory receptors in anti-tumor immunity
- (2009) Gregory Driessens et al. IMMUNOLOGICAL REVIEWS
- Recombinant single-chain variable fragment antibodies against extracellular epitopes of human multidrug resistance protein MRP3 for targeting malignant gliomas
- (2009) Chien-Tsun Kuan et al. INTERNATIONAL JOURNAL OF CANCER
- MGMTPromoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951
- (2009) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
- (2009) Karl S. Peggs et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Distribution, cellular localization, and therapeutic potential of the tumor-associated antigen Ku70/80 in glioblastoma multiforme
- (2009) Oscar Persson et al. JOURNAL OF NEURO-ONCOLOGY
- Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper
- (2009) Lara Driggers et al. JOURNAL OF NEURO-ONCOLOGY
- Gli1 is a potential target for alleviating multidrug resistance of gliomas
- (2009) Daming Cui et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers
- (2009) Sine Reker Hadrup et al. NATURE METHODS
- Activation of Wnt/β-catenin/Tcf signaling pathway in human astrocytomas
- (2009) Gangadhara Reddy Sareddy et al. NEUROCHEMISTRY INTERNATIONAL
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antigen-Specific T-Cell Response from Dendritic Cell Vaccination Using Cancer Stem-Like Cell-Associated Antigens
- (2009) Qijin Xu et al. STEM CELLS
- HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression
- (2009) James F Curtin et al. PLOS MEDICINE
- Targeting Cancer Stem Cells through L1CAM Suppresses Glioma Growth
- (2008) S. Bao et al. CANCER RESEARCH
- Low-Dose Radiation Enhances Survivin-Mediated Virotherapy against Malignant Glioma Stem Cells
- (2008) S. Nandi et al. CANCER RESEARCH
- Interleukin-13 Receptor 2, EphA2, and Fos-Related Antigen 1 as Molecular Denominators of High-Grade Astrocytomas and Specific Targets for Combinatorial Therapy
- (2008) J. Wykosky et al. CLINICAL CANCER RESEARCH
- Toxicology Study of Repeat Intracerebral Administration of a Measles Virus Derivative Producing Carcinoembryonic Antigen in Rhesus Macaques in Support of a Phase I/II Clinical Trial for Patients with Recurrent Gliomas
- (2008) Rae Myers et al. HUMAN GENE THERAPY
- Prognosis of glioma patients by combined immunostaining for survivin, Ki-67 and epidermal growth factor receptor
- (2008) Minoru Kogiku et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas
- (2008) Justin S. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients
- (2008) Mingyu Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- TIMs: central regulators of immune responses: Figure 1.
- (2008) David A. Hafler et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A phase I clinical trial of interferon-beta gene therapy for high-grade glioma: novel findings from gene expression profiling and autopsy
- (2008) Toshihiko Wakabayashi et al. JOURNAL OF GENE MEDICINE
- Tumor antigen precursor protein profiles of adult and pediatric brain tumors identify potential targets for immunotherapy
- (2008) Jian Gang Zhang et al. JOURNAL OF NEURO-ONCOLOGY
- Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme
- (2008) Shuichi Izumoto et al. JOURNAL OF NEUROSURGERY
- A Phase I Trial of Ad.hIFN-β Gene Therapy for Glioma
- (2008) E Antonio Chiocca et al. MOLECULAR THERAPY
- A Phase I Trial of Intratumoral Administration of Reovirus in Patients With Histologically Confirmed Recurrent Malignant Gliomas
- (2008) Peter Forsyth et al. MOLECULAR THERAPY
- Flt3L and TK gene therapy eradicate multifocal glioma in a syngeneic glioblastoma model
- (2007) Gwendalyn D. King et al. NEURO-ONCOLOGY
- Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma
- (2007) Duane A. Mitchell et al. NEURO-ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search